Levirate 750mg Tablet contains Levetiracetam, an antiepileptic agent indicated for the treatment of partial onset seizures, myoclonic seizures, and primary generalized tonic-clonic seizures in patients with epilepsy. Levetiracetam acts by modulating synaptic neurotransmitter release through binding to the synaptic vesicle protein SV2A, which is believed to inhibit burst firing and reduce seizure activity. This medication is typically prescribed as adjunctive therapy in adults and pediatric patients aged four years and above. Levirate 750mg is administered orally, with dosage tailored according to clinical response and patient tolerance, often initiated at a lower dose and gradually increased. The pharmacokinetic profile of Levetiracetam is characterized by rapid absorption, minimal protein binding, and renal excretion, necessitating dose adjustments in patients with renal impairment. Common adverse effects include somnolence, dizziness, headache, and fatigue, though it is generally well tolerated. Caution is advised in patients with a history of psychiatric disorders, as mood changes and behavioral symptoms have been reported. Levirate 750mg should be used under strict medical supervision, with regular monitoring to optimize therapeutic outcomes and minimize potential side effects. It is essential to adhere to prescribed dosing schedules and not discontinue therapy abruptly to avoid seizure exacerbation.